Mutation-targeted Bladder Cancer Drug Found Under-used

Bladder cancer drug targeting a cancer-driving gene mutation has been used relatively little despite its clear efficacy in a clinical trial.

Related Keywords

,Bladder Cancer ,Under Used ,Utation ,Clinical Trial ,Erdafitinib ,Urothelial Carcinomas ,